Am Heart J
- PHILLIPS LM, Jones PG, Shaw LJ, Mark DB, et al
Health Status Relationship to Ischemia and Coronary Artery Disease Severity in
the ISCHEMIA Trial.
Am Heart J. 2026 Aug 25:107586. doi: 10.1016/j.ahj.2026.107586.
- HON JJ, Aikawa T, Biering-Sorensen T, Crouch E, et al
Comparative effectiveness of influenza vaccination dosing strategies for
cardiovascular protection: a systematic review and network meta-analysis of
randomised controlled trials.
Am Heart J. 2026 Aug 24:107591. doi: 10.1016/j.ahj.2026.107591.
Am J Emerg Med
- MORRISSEY B
Acute urinary retention presenting as inferior pseudo-STEMI: A case report.
Am J Emerg Med. 2026;108:143-146.
Am J Med
- FAUCHIER L, Bouteau J, Genet T
Crossing curves, uncertain effects: Spironolactone in heart failure with
preserved ejection fraction after myocardial infarction.
Am J Med. 2026;139:e292-e293.
- PARK MK, Causland FRM, Ravi KS
Inflammation-Associated Cardiovascular Risk Differs According to SSRI Use in
Patients with Chronic Kidney Disease.
Am J Med. 2026 Aug 25:S0002-9343(26)00610-8. doi: 10.1016/j.amjmed.2026.
- CIRILLO P, Berteotti M, Galli M, Gargiulo G, et al
Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for
whom, when and how.
Am J Med. 2026 Aug 24:S0002-9343(26)00613-3. doi: 10.1016/j.amjmed.2026.
Arterioscler Thromb Vasc Biol
- GE H, Xu D, He T, Zhang Z, et al
miR487a-3p and miR6855-3p Facilitate Macrophage Proinflammatory Polarization and
Lipid Accumulation in Atherosclerosis.
Arterioscler Thromb Vasc Biol. 2026;46:e325069.
Circ Cardiovasc Interv
- TAKAHASHI T, Wei J, Ahn A, Hagena H, et al
Stability of Compounded Intracoronary Acetylcholine and Implications for
Beyond-Use Dating.
Circ Cardiovasc Interv. 2026 Aug 25:e017021.
Circ Heart Fail
- CARNICELLI AP, Lin P, Di Salvo TG, Wald JW, et al
Stepping Down Without Stepping Back: Financial Implications of Impella 5.5
Management on Cardiovascular Stepdown Units.
Circ Heart Fail. 2026 Aug 27:e014055. doi: 10.1161/CIRCHEARTFAILURE.125.014055.
Circulation
- SRIVASTAVA M
The Clinical Images in Cardiovascular Medicine Section.
Circulation. 2026;154:785.
- HASIFIC S, Ovrehus KA, Mejldal A, Hosbond S, et al
Vitamin K(2) and D(3) Supplementation in Patients With Severe Coronary Artery
Calcification: The DANCODE Trial.
Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082363.
- DAVIS JW, Manson JE
Cholecalciferol and Menaquinone Supplementation: Does Prevention of Coronary
Artery Calcium Progression Mean Heart Benefit?
Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082639.
- LAUER MS
Coronary Artery Calcium (CAC): From Marker to Treatment Target?
Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082642.
- BOHULA EA, Morrow DA
Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock.
Circulation. 2026;154:775-784.
- LU B, Liu W, Ge Z, Zou J, et al
Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs
Cardiomyocyte Cytokinesis After Myocardial Infarction.
Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.125.079049.
- MA L, Hu Y, Liu G, Rexrode KM, et al
Association of Adherence to Various Dietary Patterns With Mortality Among
Survivors of Myocardial Infarction: A Prospective Cohort Study.
Circulation. 2026 Aug 25:10.1161/CIRCULATIONAHA.126.079972.
- MILLS NL (ESC CHAIRPERSON) (UN, Kristin Newby L (ACC/AHA Co-Chairperson) (United States of America), Zaman S (WHF Co-Chairperson) (Australia), Almahmeed
Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the
Joint European Society of Cardiology (ESC)/American College of Cardiology
(ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force
for the Universal Def
Circulation. 2026 Aug 27. doi: 10.1161/CIR.0000000000001477.
Clin Cardiol
- EL-SEHRAWY AAMA, Sayed U, Nasirova Z, Tursunov Q, et al
Mechanistic Insights Into the Association Between Gut Microbiota Diversity and
Atherosclerosis, Acute Coronary Syndrome, and Peripheral Arterial Disease
Progression.
Clin Cardiol. 2026;49:e70455.
- JIANG S, Zheng Y, Pan K, Ma L, et al
Artificial Intelligence in Coronary Computed Tomography Angiography: A
Bibliometric Analysis of Trends and Themes.
Clin Cardiol. 2026;49:e70447.
- OUYANG X, Chen X, He F, Li Q, et al
Tobacco-Attributable Burden of Early-Onset Ischemic Heart Disease From 1990 to
2023: A Global Analysis Using GBD 2023 and Age-Period-Cohort Modeling.
Clin Cardiol. 2026;49:e70451.
Dtsch Med Wochenschr
- SCHNEIDER T, Laufs U
[Lipid-lowering therapy in transition: implications of the ESC/EAS focused
update].
Dtsch Med Wochenschr. 2026;151:961-967.
Eur Heart J
- SEPEHRI SHAMLOO A, Chiba T, Tijssen JGP, Althof T, et al
Mortality reduction with implanted defibrillator for primary prevention of sudden
death after Myocardial Infarction: temporal trends in the PROFID study.
Eur Heart J. 2026 Aug 28:ehag706. doi: 10.1093.
- NAIR A, van der Kaaij NP, Kluin J, Rogers J, et al
Total artificial hearts: an evolution on the horizon.
Eur Heart J. 2026;47:4396-4409.
- HEUSCH G, Kleinbongard P, Gourine AV
The vagus nerve in myocardial infarction.
Eur Heart J. 2026 Aug 26:ehag674. doi: 10.1093.
- BAI B, Cao L, Lin K, Luo C, et al
Aerobic exercise attenuates peri-infarct fibrosis and improves fitness early
after acute myocardial infarction: a randomized trial.
Eur Heart J. 2026 Aug 26:ehag651. doi: 10.1093.
- MILLS NL, Newby LK, Zaman S, Almahmeed WA, et al
Fifth Universal Definition of Myocardial Infarction (2026).
Eur Heart J. 2026 Aug 28:ehag101. doi: 10.1093.
- DE FERRARI GM, Giugliano RP, Leiter LA, Nicolau JC, et al
Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
Eur Heart J. 2026 Aug 28:ehag739. doi: 10.1093.
Heart
- SCHIOPU A, Svedlund S, Narasimhan G, Juin Loong B, et al
Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome.
Heart. 2026;112:1014-1021.
- JIN IT, Lee SJ, Lee JY, Kim SM, et al
Optical coherence tomography-guided percutaneous coronary intervention in
multivessel coronary disease with complex lesions.
Heart. 2026 Aug 26:heartjnl-2026-328499. doi: 10.1136/heartjnl-2026-328499.
- QUETSCH M, Kette F, Tavella R, Beltrame J, et al
Allergic vasospastic angina: a systematic review.
Heart. 2026;112:997-1003.
Hypertension
- CHI C, Li J, Yang H, Teliewubai J, et al
Cf-PWV Versus ba-PWV in Predicting Cardiovascular Events: Insights From a
Community-Based Cohort.
Hypertension. 2026 Aug 24. doi: 10.1161/HYPERTENSIONAHA.125.25929.
Int J Cardiol
- KATASH HA, Zornitzki L, Freund O, Loewenstein I, et al
Atrial fibrillation and coronary microvascular dysfunction-A clinical signal.
Int J Cardiol. 2026 Jul 29:134706. doi: 10.1016/j.ijcard.2026.134706.
- ARBATLI S, Yucel-Lindberg T, Thunstrom E, Peker Y, et al
Effects of CPAP on endothelial activation and fibrinolytic balance in coronary
artery disease with obstructive sleep apnea: The RICCADSA randomized controlled
trial.
Int J Cardiol. 2026;462:134701.
- HELAL A, Farooqui A, Cader FA, Giannini F, et al
Clinical outcome of coronary sinus reducer in refractory angina: A prospective
real-world observational study.
Int J Cardiol. 2026;462:134709.
- DE JONG EAM, Kapteijn DMC, Daniels MA, Nijkamp T, et al
Feasibility of endothelial cell isolation from routine coronary function testing
in ANOCA patients.
Int J Cardiol. 2026;462:134711.
- PARK J, Poletti E, Thotakura S, Kearney KE, et al
Outcomes of chronic total occlusion percutaneous coronary intervention in
patients ineligible for surgical revascularization.
Int J Cardiol. 2026;462:134716.
- EMARA A, Awashra A, Mansour A, Azim AAA, et al
Clinical and procedural outcomes of IVUS-guided versus angiography-guided PCI in
unprotected left main coronary disease: An updated meta-analysis of randomized
controlled trials.
Int J Cardiol. 2026 Aug 26:134755. doi: 10.1016/j.ijcard.2026.134755.
- GABALDON-BADIOLA A, Esquivel JR, Rumiz E, Oteo JF, et al
Endothelial dysfunction and long-term outcomes in patients with myocardial
infarction and non-obstructive coronary arteries.
Int J Cardiol. 2026 Aug 27:134750. doi: 10.1016/j.ijcard.2026.134750.
- ZHAO W, Ruan G, Wang H, Li M, et al
An interpretable machine learning approach to predict left ventricular aneurysm
formation following primary PCI in STEMI: A retrospective study with independent
external validation.
Int J Cardiol. 2026;462:134702.
- ZHONG B, King B, Mares RG, Arbanasi EM, et al
Activation of the complement lectin pathway is associated with long-term cardiac
dysfunction and incident heart failure in acute coronary syndrome patients.
Int J Cardiol. 2026 Jul 24:134699. doi: 10.1016/j.ijcard.2026.134699.
J Am Coll Cardiol
- BENOWITZ NL
Cannabis and Cardiac Ectopy: Implications for Cardiovascular Disease Prevention.
J Am Coll Cardiol. 2026 Aug 12:S0735-1097(26)07313.
- BERLACHER K, Weissman G
20 Signals, 1 Cycle: What We Did-and Didn't-Learn About Cardiovascular Disease
Fellowship Recruitment.
J Am Coll Cardiol. 2026 Aug 13:S0735-1097(26)07309.
- BLUMER V, Sinha SS, Carnicelli AP, Isseh IN, et al
Cardiogenic Shock Survivorship: A Multidisciplinary Approach Across the Continuum
of Care.
J Am Coll Cardiol. 2026;88:831-848.
- FUSTER V, Vazirani R
Interpreting Contemporary PCI for Diabetes and Multivessel Coronary Disease After
FREEDOM.
J Am Coll Cardiol. 2026;88:828-830.
- MILLS NL, Newby LK, Zaman S, Almahmeed WA, et al
Fifth Universal Definition of Myocardial Infarction (2026).
J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07248.
- NICOLAU JC, Murphy SA, Giugliano RP, Leiter LA, et al
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial
Infarction or Stroke in the VESALIUS-CV Study.
J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07440.
JAMA
- HUANG X, Petito LC, Allen NB, Blankstein R, et al
Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT
Atherosclerotic Cardiovascular Disease Equations.
JAMA. 2026 Aug 26. doi: 10.1001/jama.2026.13233.
-
Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of
36% to 50%: Research Summary.
JAMA. 2026 Aug 28:e2617332. doi: 10.1001/jama.2026.17332.
- SELVANAYAGAM JB, Cleland JGF, Hillis GS, Pasupathy S, et al
Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of
36% to 50%: The CMR GUIDE Randomized Clinical Trial.
JAMA. 2026 Aug 28. doi: 10.1001/jama.2026.17078.
- ABBASI J
Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in
New Statement.
JAMA. 2026 Aug 28. doi: 10.1001/jama.2026.17524.
- RAZO C, DeCleene NK, Johnson CO, Stark BA, et al
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study
2023.
JAMA. 2026 Jul 29:e268628. doi: 10.1001/jama.2026.8628.
Mol Cell Biochem
- WU Y, Wang X, Zhao J, Yang H, et al
Small extracellular vesicles induced by Angiotensin-(1-7) enhance
cardioprotection following myocardial ischemia-reperfusion injury.
Mol Cell Biochem. 2026 Aug 28. doi: 10.1007/s11010-026-05710.
PLoS One
- WANG G, Zhang Z, Yang G, Wang J, et al
Identification of candidate macrophage-ferroptosis crosstalk genes associated
with immune infiltration in myocardial infarction: A bioinformatics analysis.
PLoS One. 2026;21:e0356358.
Prog Cardiovasc Dis
- MALDONADO LE, Ostfeld RJ, Rodriguez CJ
Beyond diet quality for cardiovascular prevention socioeconomic context and
unequal cardiovascular risk.
Prog Cardiovasc Dis. 2026 Aug 23:S0033-0620(26)00082.
- LIU R, Arena R, Vasile VC, Arruda-Olson AM, et al
Artificial intelligence for risk prediction in atherosclerotic cardiovascular
disease: A narrative review of advances, validation challenges, and clinical
translation (2020-2026).
Prog Cardiovasc Dis. 2026 Aug 26:S0033-0620(26)00097.
- BEVERLOO CYY, Stroes ESG, Nurmohamed NS
Defining inflammation in cardiovascular risk: A complex challenge.
Prog Cardiovasc Dis. 2026 Aug 26:S0033-0620(26)00096.
Thromb Haemost
- GALUSKO V, Panoulas V, Gorog DA, Vandenbriele C, et al
Stroke in Mechanical Circulatory Supported Cardiogenic Shock.
Thromb Haemost. 2026;126:883-896.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016